VOLITIONRX LTD — Director's Dealing 2014

Sep 3, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2014-09-03

Reporting Person: Reynolds Cameron John (Director, CEO and President, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-09-03	Common Stock	G	900000	—	Acquired	1102344	Direct
2014-09-03	Common Stock	S	1038000	—	Disposed	1004088	Indirect

Footnotes

F1: The shares are held by Concord International, Inc. ("Concord") in trust. On September 3, 2014, Concord disposed of 1,038,000 total shares by gift and sale. The transaction was reported by Mr. Rodney Rootsaert and Concord on a Form 4 filed with the SEC on September 3, 2014. Mr. Reynolds is a potential beneficiary of the trust, however, any distribution will be determined by the trustee and there is not actual entitlement to a distribution of the shares.